epiglucan and Prediabetic-State

epiglucan has been researched along with Prediabetic-State* in 1 studies

Trials

1 trial(s) available for epiglucan and Prediabetic-State

ArticleYear
Sixteen-week multicentre randomised controlled trial to study the effect of the consumption of an oat beta-glucan-enriched bread versus a whole-grain wheat bread on glycaemic control among persons with pre-diabetes: a study protocol of the CarbHealth stud
    BMJ open, 2022, 08-23, Volume: 12, Issue:8

    In 2012, the estimated global prevalence of pre-diabetes was 280 million, and the prevalence is expected to rise to 400 million by 2030. Oat-based foods are a good source of beta-glucans, which have been shown to lower postprandial blood glucose. Studies to evaluate the effectiveness of the long-term intake of beta-glucan-enriched bread as part of a habitual diet among individuals with pre-diabetes are needed. Therefore, we designed a multicentre intervention study in adults with pre-diabetes to investigate the effects of consumption of an oat-derived beta-glucan-enriched bread as part of a normal diet on glycated haemoglobin (HbA1c) in comparison to consumption of whole-grain wheat bread.. The study protocol was approved by respective ethical authorities in participating countries. The results of the study will be communicated through publication in international scientific journals and presentations at (inter)national conferences.. NCT04994327.

    Topics: Adult; beta-Glucans; Blood Glucose; Bread; Glycated Hemoglobin; Glycemic Control; Humans; Multicenter Studies as Topic; Prediabetic State; Randomized Controlled Trials as Topic; Triticum

2022